Impact of Exercise Training on Cardiac Function in Man

Effects of Exercise Training on Cardiac Function and Lipid Metabolism in Mem 18-22 Year Old

The purpose of this study is to monitor the impact of exercise training on cardiac functions and lipoprotein lipids.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Exercise can increase the mass of left ventricle, which is also called athletic heart. Athletic heart is most frequently encountered as a pathological manifestation of cardiovascular disease, and the early determinants of athelitic remodeling in the general population are largely unknown. We will recruit 45 men aged 18-25 years who will run 5000 meters 2/day for 3 months. caridac function is examined by ECG and echocardiogram, blood pressure, lipoprotein, heart rate, body weight, cardiac troponin will be examined prior to exercise program and 3 months after exercise.

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Henan
      • Luoyang, Henan, China, 471000
        • No. 150 Central hospital of Chinese People's Liberation Army

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 22 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • men
  • age 18-25 years
  • body mass index (BMI) 18-25 kg/m2
  • no regular exercise
  • no tobacco use
  • no current use of prescribed medications
  • no self-report of acute of chronic diseases

Exclusion Criteria:

  • conditions that do not meet the inclusion criteria listed.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental 1
men with exercise training for 3 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
change of cardiac function at baseline to exercise training for 3 months
Time Frame: baseline to 3 months
baseline to 3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
change of lipoprotein at baseline to exercise training for 3 months
Time Frame: baseline to 3 months
baseline to 3 months
change of heart rate at baseline to exercise training for 3 months
Time Frame: baseline to 3 months
baseline to 3 months
Change of body weight at baseline to exercise training for 3 months
Time Frame: baseline to 3 months
baseline to 3 months
change of cardiac troponin frome baseline to exercise training for 3 months
Time Frame: baselin to 3 months
baselin to 3 months
Change of blood pressure from baseline to exercise training for 3 months
Time Frame: baseline to 3 months
baseline to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Shenxu Wang, MD, No. 150 Central Hospital of PLA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Actual)

May 1, 2013

Study Completion (Actual)

May 1, 2013

Study Registration Dates

First Submitted

June 12, 2013

First Submitted That Met QC Criteria

June 17, 2013

First Posted (Estimate)

June 19, 2013

Study Record Updates

Last Update Posted (Estimate)

June 19, 2013

Last Update Submitted That Met QC Criteria

June 17, 2013

Last Verified

June 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 150CTSX002

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Disease

Clinical Trials on exercise training

Subscribe